Chemotherapy Induces Tumor Clearance Independent of Apoptosis

American Association for Cancer Research (AACR) - Tập 68 Số 23 - Trang 9595-9600 - 2008
Jennifer L. Guerriero1, Dara Ditsworth2, Yongjun Fan3,4, Fangping Zhao2, Howard C. Crawford5, Wei‐Xing Zong3,4
1Graduate Program in Molecular and Cellular Biology, Department of Molecular Genetics, Stony Brook University, Stony Brook, New York 11794-5222, USA.
24Abramson Family Cancer Research Institute, Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania
32Molecular Genetics and Microbiology and
4Stony Brook University
53Pharmacological Sciences, Stony Brook University, Stony Brook, New York; and

Tóm tắt

Abstract Dysregulation of apoptosis is associated with the development of human cancer and resistance to anticancer therapy. The ultimate goal of cancer treatment is to selectively induce cancer cell death and overcome drug resistance. A deeper understanding of how a given chemotherapy affects tumor cell death is needed to develop strategically designed anticancer agents. Here, we use a xenograft mouse tumor system generated from genetically defined cells deficient in apoptosis to examine the involvement of multiple forms of cell death induced by cyclophosphamide (CP), a DNA alkylating agent commonly used in chemotherapy. We find that although apoptosis facilitates tumor regression, it is dispensable for complete tumor regression as other forms of cell death are activated. Sporadic necrosis is observed in both apoptosis-competent and deficient tumors evident by tumor cell morphology, extracellular release of high mobility group box 1 protein, and activation of innate immune cells in CP-treated tumors. Our findings indicate that in apoptosis-deficient tumors, necrosis may play a fundamental role in tumor clearance by stimulating the innate immune response. [Cancer Res 2008;68(23):9595–600]

Từ khóa


Tài liệu tham khảo

Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57–70.

Okada H, Mak TW. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004; 4: 592–603.

Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007; 26: 1324–37.

Chabner BA, Longo DL. Cancer Chemotherapy and Biotherapy. Principles and Practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.

Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 2005; 5: 231–7.

Melino G, Knight RA, Nicotera P. How many ways to die? How many different models of cell death? Cell Death Differ 2005; 12 Suppl 2: 1457–62.

Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer 2007; 7: 961–7.

Wei MC, Zong WX, Cheng EH, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292: 727–30.

Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004; 23: 2825–37.

Rhodin JAG. Histology. A Text and Atlas. New York (NY): Oxford University Press; 1974. p. 371–98.

Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191–5.

Kwon CH, Borch RF, Engel J, Niemeyer U. Activation mechanisms of mafosfamide and the role of thiols in cyclophosphamide metabolism. J Med Chem 1987; 30: 395–9.

Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998; 101: 890–8.

Zeh HJ III, Lotze MT. Addicted to death: invasive cancer and the immune response to unscheduled cell death. J Immunother 2005; 28: 1–9.

Hardonk MJ, Dijkhuis FW, Hulstaert CE, Koudstaal J. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol 1992; 52: 296–302.

Mizgerd JP, Molina RM, Stearns RC, Brain JD, Warner AE. Gadolinium induces macrophage apoptosis. J Leukoc Biol 1996; 59: 189–95.

Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol 2004; 4: 641–8.

Thông tin
Thông tin xuất bản

American Association for Cancer Research (AACR)

Tập 68 Số 23

9595-9600

Thông tin tác giả